Anti-VEGF neutralizing antibody delays osteomucosal healing by reducing collagen formation in mice

By afschroeder • October 23, 2025

Bae EB, Kim MY, Ji S, Cho IW, Kim SY, Esmaeili M, Baik SS, Kim S, Tetradis S, Park NH, Gwack Y, Kim RH. Anti-VEGF neutralizing antibody delays osteomucosal healing by reducing collagen formation in mice. Sci Rep. 2025 Oct 22;15(1):36903. doi: 10.1038/s41598-025-20840-x. PMID: 41125686.

Tags: Anti-VEGF antibody, Bevacizumab, Extraction, Healing, Hematology/Oncology, MRONJ, periodontitis, Publications

Analyses of adverse events and patient-reported outcomes with the toxicity index in cancer clinical trials

Gresham G, Henry NL, Bandos H, Calsavara VF, Cecchini RS, Diniz MA, Hays RD, Luu M, Kim S, Rogatko A, Yothers G, Ganz PA, Tighiouart[...]

Collagen-binding IL-12-armoured STEAP1 CAR-T cells reduce toxicity and treat prostate cancer in mouse models

Sasaki K, Bhatia V, Asano Y, Bakhtiari J, Kaur P, Wang C, Matsuo T, Dubois O, Chiu PC, Gun D, Singh C, Panagi I, Noblecourt[...]

Epstein-Barr Virus-Positive Lymphoproliferative Disorder in an HIV Patient Successfully Treated With Rituximab

Karapetians AG, Ayyagari T, Montana W. Epstein-Barr Virus-Positive Lymphoproliferative Disorder in an HIV Patient Successfully Treated With Rituximab. Cureus. 2025 Sep 21;17(9):e92816. doi: 10.7759/cureus.92816. PMID:[...]